Clinical trial Recruiting at 2 sites Interventional Ages 0 to 21

Philips FAST SpO2 monitoring with Masimo neonatal, infant, and pediatric sensors

Official title: Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations

Run by Masimo Corporation · NCT07223177 · Data updated 2026-11-12

This project will test whether Philips FAST SpO2 technology works correctly with Masimo sensors to measure blood oxygen in newborns, infants, and children.

More SpO2 trials

Quick facts

Study typeInterventional
Ages0 Years to 21 Years
SexAll
Enrollment100 (estimated)
SponsorMasimo Corporation
Industry-sponsored
Locations2 sites (Modesto, California and 1 other locations)
StatusRecruiting
StartedDecember 17, 2025
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedJuly 13, 2026
Trial IDNCT07223177 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are neonates, infants, and pediatric patients under 22 years who fall within the indicated populations for the Philips FAST monitor and can tolerate standard sensor placement without exclusion criteria.

Probably not a fit

Patients with skin conditions at the sensor site, distinct localized pigmentary anomalies (e.g., vitiligo at the site), absence/deformity of limbs, severe edema, or who refuse removal of interfering nail polish/acrobatics are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional convenience-sample study will connect Masimo neonatal, infant, and pediatric sensors (RD SET and/or LNCS) to a Philips monitor running the FAST SpO2 algorithm to verify form, fit, and function. Data will be collected from indicated patient populations (neonates through age 21) across a range of skin pigmentations. Measurements will be taken simultaneously with an FDA-cleared pulse oximeter as a comparator to compare readings. The aim is to confirm reliable sensor performance and proper sensor fit in the intended pediatric populations.

Why it matters

Potential benefit: If successful, this could improve availability of compatible sensor-monitor pairings and help ensure accurate oxygen readings for babies and children using Masimo sensors with Philips monitors.

How similar studies have gone: Masimo sensors and pulse oximetry have been validated in prior studies, but the specific integration and verification of Masimo sensors with Philips' FAST algorithm is a focused compatibility check being performed here.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Subject falls within the indicated population for the Philips FAST SpO2 Monitor with the Masimo sensor.
* Subject is less than 22 years of age (pediatric subject per US FDA definition).

Exclusion Criteria:

* Subject has a skin condition or deformity at the planned sensor application site, which would preclude sensor placement and measurements as standard of care (e.g., psoriasis, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown).
* Confounders of pulse oximetry per sensor direction for use (DFU).
* Subject with distinct geographic variances in skin pigmentation (e.g., vitiligo), where the sensor is applied.
* Subject has an absence or deformities of limbs or severe edema, which would interfere with sensor application or prevent the proper fit of the sensors.
* Subject with nail polish or acrylic nails on the digits where sensor needs to be applied, who opts to not remove it.
* Subject with known allergic reactions to adhesive tapes.
* Subject is not suitable for the investigation at the discretion of the clinical research team.

Where it's running

  • Paradigm Clinical Research
    Modesto, California, United States
    Recruiting
  • Paradigm Clinical Research
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.